162 related articles for article (PubMed ID: 2438389)
1. Primary chemotherapy for clinical stage II nonseminomatous germ cell tumors of the testis: a follow-up of 50 patients.
Logothetis CJ; Swanson DA; Dexeus F; Chong C; Ogden S; Ayala AG; von Eschenbach AC; Johnson DE; Samuels ML
J Clin Oncol; 1987 Jun; 5(6):906-11. PubMed ID: 2438389
[TBL] [Abstract][Full Text] [Related]
2. Early clinical stages of nonseminomatous testis cancer. Evaluation of the primary treatment and follow-up procedures of the SWENOTECA project.
Klepp O; Olsson AM; Ous S; Nilsson S; Høisaether PA; Tveter K
Scand J Urol Nephrol; 1991; 25(3):179-90. PubMed ID: 1658924
[TBL] [Abstract][Full Text] [Related]
3. Patient selection for retroperitoneal lymph node dissection after chemotherapy for nonseminomatous germ cell tumors.
Herr HW; Toner GC; Geller NL; Bosl GJ
Eur Urol; 1991; 19(1):1-5. PubMed ID: 1848821
[TBL] [Abstract][Full Text] [Related]
4. The role of chemotherapy and surgery in the treatment of retroperitoneal metastases in advanced nonseminomatous testis cancer.
Vugrin D; Whitmore WF
Cancer; 1985 May; 55(9):1874-8. PubMed ID: 4038913
[TBL] [Abstract][Full Text] [Related]
5. Management of patients with clinical stage I or II nonseminomatous germ cell tumors of the testis. Evolving therapeutic options.
Richie JP; Socinsky MA; Fung CY; Brodsky GL; Kalish LA; Garnick MB
Arch Surg; 1987 Dec; 122(12):1443-5. PubMed ID: 2446590
[TBL] [Abstract][Full Text] [Related]
6. Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selection.
Toner GC; Panicek DM; Heelan RT; Geller NL; Lin SY; Bajorin D; Motzer RJ; Scher HI; Herr HW; Morse MJ
J Clin Oncol; 1990 Oct; 8(10):1683-94. PubMed ID: 2170590
[TBL] [Abstract][Full Text] [Related]
7. Improved survival with cyclic chemotherapy for nonseminomatous germ cell tumors of the testis.
Logothetis CJ; Samuels ML; Selig D; Swanson D; Johnson DE; von Eschenbach AC
J Clin Oncol; 1985 Mar; 3(3):326-35. PubMed ID: 2579213
[TBL] [Abstract][Full Text] [Related]
8. Is postchemotherapy retroperitoneal surgery necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses?
Fosså SD; Qvist H; Stenwig AE; Lien HH; Ous S; Giercksky KE
J Clin Oncol; 1992 Apr; 10(4):569-73. PubMed ID: 1312586
[TBL] [Abstract][Full Text] [Related]
9. Clinical stage II non-seminomatous germ cell testicular tumours. Results of management by primary chemotherapy.
Peckham MJ; Hendry WF
Br J Urol; 1985 Dec; 57(6):763-8. PubMed ID: 2417652
[TBL] [Abstract][Full Text] [Related]
10. Stage II nonseminomatous germ cell tumors of the testis: an analysis of treatment options in patients with low volume retroperitoneal disease.
Socinski MA; Garnick MB; Stomper PC; Fung CY; Richie JP
J Urol; 1988 Dec; 140(6):1437-41. PubMed ID: 2848138
[TBL] [Abstract][Full Text] [Related]
11. Vascular invasion as a prognosticator of metastatic disease in nonseminomatous germ cell tumors of the testis. Importance in "surveillance only" protocols.
Moriyama N; Daly JJ; Keating MA; Lin CW; Prout GR
Cancer; 1985 Nov; 56(10):2492-8. PubMed ID: 2412688
[TBL] [Abstract][Full Text] [Related]
12. Germ-cell tumors of the testis: improved results in a prospective study using combined modality therapy and biochemical tumor markers.
Scardino PT; Skinner DG
Surgery; 1979 Jul; 86(1):86-93. PubMed ID: 88077
[No Abstract] [Full Text] [Related]
13. Histology of tumor residuals following chemotherapy in patients with advanced nonseminomatous testicular cancer.
Fosså SD; Aass N; Ous S; Høie J; Stenwig AE; Lien HH; Paus E; Kaalhus O
J Urol; 1989 Nov; 142(5):1239-42. PubMed ID: 2478726
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors in clinical stage I nonseminomatous germ cell tumors of the testis: multivariate analysis of a prospective multicenter study. Swedish-Norwegian Testicular Cancer Group.
Klepp O; Olsson AM; Henrikson H; Aass N; Dahl O; Stenwig AE; Persson BE; Cavallin-Ståhl E; Fosså SD; Wahlqvist L
J Clin Oncol; 1990 Mar; 8(3):509-18. PubMed ID: 1689773
[TBL] [Abstract][Full Text] [Related]
15. Cisplatin, etoposide, bleomycin first-line therapy and early resection of residual tumor in far-advanced germinal testis cancer.
Pizzocaro G; Piva L; Salvioni R; Zanoni F; Milani A
Cancer; 1985 Nov; 56(10):2411-5. PubMed ID: 2412683
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy of extragonadal germ cell tumors.
Logothetis CJ; Samuels ML; Selig DE; Dexeus FH; Johnson DE; Swanson DA; von Eschenbach AC
J Clin Oncol; 1985 Mar; 3(3):316-25. PubMed ID: 2579212
[TBL] [Abstract][Full Text] [Related]
17. Retroperitoneal lymph node dissection in clinical stage IIA and IIB nonseminomatous germ cell tumours of the testis.
Pizzocaro G
Int J Androl; 1987 Feb; 10(1):269-75. PubMed ID: 3034796
[TBL] [Abstract][Full Text] [Related]
18. Early clinical stages (CS1, CS1Mk+ and CS2A) of non-seminomatous testis cancer. Value of pre- and post-orchiectomy serum tumor marker information in prediction of retroperitoneal lymph node metastases. Swedish-Norwegian Testicular Cancer Project (SWENOTECA).
Klepp O; Flodgren P; Maartman-Moe H; Lindholm CE; Unsgaard B; Teigum H; Fosså SD; Paus E
Ann Oncol; 1990 Jul; 1(4):281-8. PubMed ID: 1702312
[TBL] [Abstract][Full Text] [Related]
19. Stage I nonseminomatous germ cell testicular tumor: prediction of metastatic potential by primary histopathology.
Fung CY; Kalish LA; Brodsky GL; Richie JP; Garnick MB
J Clin Oncol; 1988 Sep; 6(9):1467-73. PubMed ID: 2843611
[TBL] [Abstract][Full Text] [Related]
20. Current perspectives on the role of adjunctive surgery in combined modality treatment for patients with germ cell tumors.
Bajorin DF; Herr H; Motzer RJ; Bosl GJ
Semin Oncol; 1992 Apr; 19(2):148-58. PubMed ID: 1372757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
